Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Feature | Pharmaceuticals | May 16, 2017

May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting...

Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR, SCAI 2017 late-breaking clinical trial
News | Stroke | May 12, 2017

May 12, 2017 — More than one-third of patients undergoing...

anticoagulants increase dementia risks
Feature | Antiplatelet and Anticoagulation Therapies | May 12, 2017

May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for...

Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.

Feature | Point of Care Testing | May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on...

Prescribing Patterns Change Following Direct Marketing Restrictions
News | Pharmaceuticals | May 05, 2017

May 5, 2017 — A study of how policies restricting...

An electrophysiology EP ablation procedure to treat a heart arrhythmia
Feature | HRS | May 16, 2017

May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017...

EBBINGHAUS study, evolocumab, repatha, statin therapy, cognitive issues, ACC.17 study
News | Pharmaceuticals | April 03, 2017

April 3, 2017 — There is no evidence that adding a new...

Ablation procedure, EP lab, Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation
Feature | Atrial Fibrillation | March 29, 2017

March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K,...

synthetic HDL-C injection, cholesterol, arterial plaque, heart attack patients, CARAT trial, ACC.17, clinical study
News | Pharmaceuticals | March 29, 2017

March 29, 2017 — Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good...

PCI, drugs, medication, fully blocked arteries, chronic total occlusion, ACC.17, clinical study
News | Chronic Total Occlusion (CTO) | March 29, 2017 | Dave Fornell

March 29, 2017 — In patients with a complete, persistent arterial blockage, medication alone was found to be equal...

heart-lung machine, ECMO, levosimendan, heart failure drug, cardiovascular surgery outcomes, ACC.17 study
News | Pharmaceuticals | March 28, 2017

March 28, 2017 — When used as a preventive measure during heart surgery, the heart failure...

ECRI Institute, top 10 patient safety concerns, 2017 report, information technology, healthcare
News | Information Technology | March 24, 2017

March 24, 2017 — Safe implementation of...

bleeding complications, rivaroxaban, antiplatelet therapy, post-ACS, acute coronary syndrome, ACC.17 study
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017

March 23, 2017 — Bleeding complications did not increase for patients with acute coronary syndrome treated with...

rivaroxaban, asprin, venous thromboembolism, VTE recurrence, clinical study, ACC.17
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017

March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low...

Overlay Init